Results 61 to 70 of about 5,366 (262)

Modern possibilities of pathogenetic therapy of patients with allergic rhinitis

open access: yesМедицинский совет, 2020
The incidence of allergic rhinitis has been increasing rapidly worldwide in recent years. About 40% of the world’s population suffer from allergic inflammation of the nasal mucous membrane.
V. M. Svistushkin   +3 more
doaj   +1 more source

Rising Health Care Costs and Life-Cycle Management in the Pharmaceutical Market [PDF]

open access: yes, 2013
Aaron Kesselheim discusses Natalie Vernaz and colleagues' paper on the effects on health care costs of “evergreening” strategies pursued by drug manufacturers.
Kesselheim, Aaron S.
core   +2 more sources

Idiosyncratic Liver Injury Due to Levocetirizine

open access: yesACG Case Reports Journal, 2019
ABSTRACT Levocetirizine is an over-the-counter nonsedating antihistaminic agent commonly used to treat allergic diseases. Clinically significant acute liver injury has been very rarely associated with its use. Only 2 cases of acute liver injury associated with levocetirizine have been reported in the literature.
Mary Barbara   +2 more
openaire   +3 more sources

Effectiveness of levocetirizine in treating allergic rhinitis while retaining work efficiency

open access: yesArchives of Asthma Allergy and Immunology, 2023
The manifestation and severity of Allergic rhinitis symptoms show diurnal variation which negatively impacts the patient’s quality of life, day-to-day activities, and productivity at the workplace.
Y. Dabholkar   +7 more
semanticscholar   +1 more source

In-Vitro Comparative Study of Levocetirizine Dihydrochloride and Montelukast Sodium Release Profiles in Xyzal M Suspension and Other Marketed Syrup Formulations

open access: yesJournal of Drug Delivery and Therapeutics, 2023
Objectives: In-vitro comparative analysis of the release profile of levocetirizine dihydrochloride and montelukast sodium in Xyzal M Suspension and three commercially available syrup formulations.
D. Joshi   +3 more
semanticscholar   +1 more source

POSSIBILITIES OF USE OF THE MODERN ANTIHISTAMINE MEDICINES IN THERAPY OF PATIENTS WITH ALLERGIC RHINITIS

open access: yesМедицинский совет, 2017
Allergic rhinitis as one of the most common non-infectious respiratory inflammatory diseases is a global public health problem. The course of allergic rhinitis, its effect on the pathology of other organs and systems, the likelihood of complications and ...
G. N. Nikiforova   +3 more
doaj   +3 more sources

Self-report prevalence and associated factors to drug hypersensitivity in Mexican young adults [PDF]

open access: yes, 2017
Background: Drug hypersensitivity is defined as any unfavorable reaction that occurs after the administration of any drug. It may or may not be mediated by the involvement of the immune system.
BEDOLLA BARAJAS, MARTIN   +9 more
core   +1 more source

Enantioselective Intramolecular α-Arylation of Benzylamine Derivatives: Synthesis of a Precursor to Levocetirizine.

open access: yesAngewandte Chemie, 2023
A practical, transition metal-free method allows the enantioselective synthesis of α,α-diarylmethylamines by asymmetric α-arylation of benzylamines.
Rakesh K. Saunthwal   +4 more
semanticscholar   +1 more source

Minimal Clinically Important Difference (MCID) in Allergic Rhinitis: Agency for Healthcare Research and Quality or Anchor-Based Thresholds? [PDF]

open access: yes, 2016
BackgroundIn 2013, the Agency for Healthcare Research and Quality (AHRQ) recommended that allergic rhinitis (AR) studies calculate a minimal clinically important difference (MCID) based on an estimated threshold equal to 30% of the maximum total nasal ...
Dykewicz, Mark   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy